|
Crane Holdings, Co. (CR): BCG Matrix [Apr-2026 Updated] |
Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
Design Profissional: Modelos Confiáveis E Padrão Da Indústria
Pré-Construídos Para Uso Rápido E Eficiente
Compatível com MAC/PC, totalmente desbloqueado
Não É Necessária Experiência; Fácil De Seguir
Crane Holdings, Co. (CR) Bundle
You're looking for a clear-eyed view of Crane Holdings, Co.'s (CR) portfolio, and the BCG Matrix is defintely the right tool to map where the cash is flowing and where the future growth lies. We've mapped the business units based on late 2025 performance: the high-growth Aerospace & Electronics segment is clearly a Star, fueled by a 20% aftermarket surge and a 25.1% operating margin, while the massive Process Flow Technologies segment acts as the reliable Cash Cow, generating substantial cash flow from its $319.0 million in Q3 sales. Still, the portfolio isn't all clear sailing; we need to watch the capital drain from new ventures like the PSI acquisition, which are currently Question Marks, and identify the legacy areas that are now Dogs following the Engineered Materials divestiture. Dive in to see exactly where Crane Holdings, Co. needs to invest, hold, or prune resources right now.
Background of Crane Holdings, Co. (CR)
You're looking at Crane Company, a firm that's been around since 1855, now focused on highly engineered components for specific, demanding industries. Honestly, the company has streamlined its focus recently, completing the divestiture of its Engineered Materials segment effective January 1, 2025. This leaves the core business centered on two main areas: Aerospace & Electronics and Process Flow Technologies.
As of late 2025, the momentum seems strong, especially given the updated full-year outlook. Crane Company raised its revenue growth forecast for fiscal year 2025 to approximately 7.5%. That's up from an earlier projection of 6.5%. The initial full-year adjusted earnings per share (EPS) guidance for 2025, which started at $5.30 to $5.60, was later increased to a range of $5.75 to $5.95 by the third quarter results.
Let's look at the most recent snapshot, the third quarter of 2025. Sales for that quarter hit $589.2 million, marking a 7.5% increase year-over-year. Adjusted EPS from continuing operations was $1.64, which is a 27% jump compared to the third quarter of 2024. You can see the operational leverage working there.
The Aerospace & Electronics segment is definitely the growth engine right now. In Q3 2025, its sales jumped 13.0% compared to the prior year, driven by strength in both original equipment and aftermarket sales. As of the second quarter end, its order backlog was over $1 billion, showing significant future revenue visibility. The Process Flow Technologies segment, while showing more modest growth, still contributed, with its order backlog sitting at $383.0 million at the end of September 2025.
Financially, the balance sheet looks solid for a manufacturer of this type. At the close of the first quarter of 2025, Crane Company reported a cash balance of $435.1 million against total debt of $247.1 million. The company is definitely positioned to invest in its core platforms, which is what we'll need to map out next.
Crane Holdings, Co. (CR) - BCG Matrix: Stars
You're looking at the segment of Crane Holdings, Co. (CR) that is clearly leading the charge in a high-growth environment. These are the units where market share is strong, and the expectation is they will transition into Cash Cows once the market growth rate naturally decelerates. For Crane Holdings, Co. (CR) as of Q3 2025, the Aerospace & Electronics (A&E) segment fits this description perfectly, demanding significant investment to maintain its leadership position.
Here's a snapshot of the Q3 2025 performance metrics for the A&E segment, which solidifies its Star status:
| Metric | Value | Context |
| Sales Growth (YoY) | 13.0% | Indicates high market growth |
| Adjusted Operating Margin | 25.1% | Shows strong competitive position |
| Core Backlog Growth (YoY) | 16.4% | Secures future revenue streams |
| Aftermarket Sales Growth (YoY) | 20% | Drives high-margin revenue |
The growth story here is quite compelling, especially when you look at the recurring revenue component. The A&E segment is not just growing; it's building a solid foundation for future earnings. If market share is kept, Stars are likely to grow into cash cows, and the data suggests Crane Holdings, Co. (CR) is doing the work to keep that share.
- Aerospace & Electronics (A&E) segment sales were up 13.0% YoY in Q3 2025.
- Aftermarket sales within A&E surged 20% in the quarter.
- Segment's core backlog growth reached 16.4% in Q3 2025.
- Core orders were up 2%, complementing the backlog strength.
Profitability is another key indicator of a Star's strength. A high adjusted operating margin in a growth market means the unit is effectively converting sales into profit, even while consuming cash for expansion. The A&E segment posted an adjusted operating margin of 25.1% in Q3 2025, which is a 160 basis point expansion from the prior year. This level of profitability, combined with the high growth, is exactly what you want to see in a Star; it's leading the business but is also highly efficient at what it does. Finance: draft the investment allocation plan for A&E based on this margin strength by next Tuesday.
Crane Holdings, Co. (CR) - BCG Matrix: Cash Cows
You're looking at the core engine of Crane Holdings, Co.'s current financial strength, which is the Process Flow Technologies (PFT) segment. This business unit fits the Cash Cow profile perfectly: it commands a high market share in a mature industrial space, meaning growth is steady rather than explosive, but the profitability is excellent.
For the third quarter of 2025, PFT was the largest contributor to the top line, delivering sales of $319.0 million. This volume, combined with strong internal discipline, translates directly into high cash generation. The adjusted operating margin for the segment in Q3 2025 was 22.4%, which is a strong indicator of the competitive advantage and pricing power this market leader holds. Cash cows are what you want to see because they generate more cash than they consume, funding the rest of the portfolio.
The growth profile confirms its maturity. For the full year 2025, the projection for PFT core sales growth is in the low to mid-single-digit range, which is exactly what you expect from a dominant player in a stable market. In the third quarter itself, core performance was reported as flat, reinforcing the low-growth, high-share dynamic. This stability allows Crane Holdings, Co. to keep investment spending low, focusing instead on efficiency improvements that boost cash flow further.
Here's a quick look at the Q3 2025 snapshot for the PFT segment, showing why it's such a reliable cash generator:
| Metric | Value (Q3 2025) | Context |
|---|---|---|
| Segment Sales | $319.0 million | Largest segment by sales volume. |
| Adjusted Operating Margin | 22.4% | High profitability reflecting market leadership. |
| Core Sales Performance | Flat | Confirms mature market status. |
| Free Cash Flow Margin (Company-wide) | 19.8% | Indicates strong conversion of profit to cash. |
The stability from PFT is what underpins the company's commitment to its shareholders. You can see this clearly in the dividend policy, which is supported by this segment's consistent cash generation. Crane Holdings, Co. raised its annual dividend by 12% for 2025, setting the expected annual payout at $0.92 per share. The most recent declared quarterly dividend was $0.23 per share for the fourth quarter of 2025.
What this estimate hides is the low payout ratio, which suggests the dividend is very safe and well-covered by earnings and cash flow. This is the definition of milking a cash cow-you take the necessary cash for the dividend but retain plenty for infrastructure support and other corporate needs.
- Annual Dividend Payout (Projected 2025): $0.92 per share.
- Quarterly Dividend Payment (Q4 2025): $0.23 per share.
- Payout Ratio based on Earnings (2025): 16.6%.
- Payout Ratio based on Free Cash Flow (2025): 15.9%.
- Dividend Growth Streak: Increased dividends for 2 consecutive years.
The low payout ratio, defintely, shows that Crane Holdings, Co. is not stretching itself to pay the dividend; it's comfortably funded by the cash generated from these mature, high-share businesses. You should expect management to continue investing selectively in infrastructure within PFT to maintain that 22.4% margin, rather than pouring money into aggressive market expansion. Finance: draft 13-week cash view by Friday.
Crane Holdings, Co. (CR) - BCG Matrix: Dogs
You're looking at the parts of Crane Holdings, Co. (CR) portfolio that aren't driving significant growth or market share right now. These are the units that tie up capital without offering much return, and the company has been actively pruning them.
The most significant recent action aligning with minimizing Dogs was the divestiture of the Engineered Materials segment. Crane closed this sale to KPS Capital Partners, LP on January 1, 2025, for a total consideration of $227 million. This move was explicitly about simplifying the portfolio and focusing resources on the two strategic growth platforms, which is the textbook approach for dealing with a unit that no longer fits the growth profile.
Within the remaining structure, the Process Flow Technologies (PFT) segment contains areas that fit the Dog profile, specifically certain mature, non-core product lines facing mixed industrial demand signals. While the overall segment is stable, the data points to stagnation in specific sub-areas.
Here's a quick look at how the core segments stacked up in Q3 2025, showing where the focus isn't:
| Metric | Aerospace & Electronics (Star/Cash Cow Potential) | Process Flow Technologies (Contains Dogs) |
|---|---|---|
| Q3 2025 Sales | $270.2 million | $319.0 million |
| Core Sales Growth (YoY) | 12.8% | Flat |
| Order Backlog (End of Q3 2025) | $1,054.1 million | $383.0 million |
| Core FX-Neutral Backlog Change (YoY) | Up 27% (Implied from total backlog growth vs. A&E sales) | Decreased 5% |
The PFT segment's order backlog saw a slight decrease to $383.0 million as of September 30, 2025, down from $403.1 million in the prior quarter. Compared to September 30, 2024, the backlog was $392.0 million. This sequential and year-over-year drop in backlog, coupled with flat core performance in Q3 2025, suggests that some core product areas within PFT are definitely stagnant, fitting the low-growth, low-market-share description of a Dog.
Strategically, these Dog units-which often include low-growth, highly competitive component manufacturing areas with limited proprietary content-are candidates for divestiture or minimal investment. You want to avoid sinking capital into expensive turn-around plans here.
- Avoid significant new capital investment in these units.
- Focus on maximizing short-term cash flow from existing assets.
- Prepare for potential divestiture to free up capital for Stars or strong Cash Cows.
- These units frequently break even, neither consuming nor generating substantial cash.
- The goal is to minimize the cash traps tied up in low-return activities.
Finance: review the carrying value and depreciation schedule for all non-core PFT assets by next Wednesday.
Crane Holdings, Co. (CR) - BCG Matrix: Question Marks
You're looking at the business units or ventures within Crane Holdings, Co. (CR) that are currently in high-growth markets but haven't yet secured a dominant market share. These are the Question Marks, and they are cash hungry right now, but they hold the potential to become tomorrow's Stars.
The most significant recent example of a major capital deployment fitting this profile is the announced acquisition of Precision Sensing and Instrumentation (PSI) from Baker Hughes. Crane agreed to purchase PSI for $1,060 million, or about $1.2 billion. This transaction, expected to close by January 1, 2026, requires significant upfront capital, which is characteristic of a Question Mark needing heavy investment to integrate and grow. PSI is forecast to generate approximately $60 million in adjusted EBITDA for 2025 on estimated 2025 sales of about $390 million. Crane expects this acquisition to achieve a 10% Return on Invested Capital (ROIC) by year five. Following this deal, Crane anticipates its net leverage will settle at approximately 1x, still leaving them with substantial capacity for further strategic moves, estimated at over $1.5 billion after the PSI transaction.
Within the Process Flow Technologies (PFT) segment, cryogenic and space launch platforms represent a clear Question Mark area. Crane is actively building market share here through bolt-on acquisitions. For instance, the acquisition of CryoWorks added $28 million in annual sales, and the Technifab acquisition was valued at $40 million in sales. In Q2 2025, PFT sales reached $319.0 million, with acquisitions contributing 3.2% to that total, alongside 2.6% core sales growth. This market is definitely growing; the global space cryogenics market was valued at USD 19.1 billion in 2024 and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.3% from 2025 to 2034. North America, driven by government and private space exploration, held over 34.6% of the revenue share in 2024.
Here's a quick look at how these recent acquisitions, which are being integrated into high-growth areas, compare to the segment performance:
| Metric | PSI (Acquisition Estimate) | CryoWorks/Technifab (Acquisition Impact) | PFT Segment (Q2 2025) |
|---|---|---|---|
| 2025 Sales (Approx.) | $390 million | Combined impact on sales | $319.0 million (Total Sales) |
| 2025 Adjusted EBITDA (Approx.) | $60 million | Not specified | Not specified |
| Sales Growth Contribution (Q2 2025) | N/A (Closing later) | 3.2% of sales growth | 3% Year-over-Year Sales Increase |
| Adjusted Operating Margin | Expected leverage at 35% on operating profit | N/A | 20.0% (Q2 2025) / 22.4% (Q3 2025) |
New product development initiatives in defense electronics also fall into this category. While the Aerospace & Electronics segment delivered a record adjusted segment margin of 26.3% in Q2 2025 and saw sales increase by 11.8% in that quarter, new electronic products require high Research and Development (R&D) spend before they achieve proven market success and scale. The segment's strong demand is evidenced by its backlog growing 29.2% year-over-year to $1,052.8 million as of Q2 2025. This backlog growth signals high future demand but the initial investment to bring new defense electronics to market consumes cash before returns materialize.
Crane Holdings, Co. is clearly committed to investing in these growth vectors, as its M&A pipeline remains robust. The strategy for these Question Marks is clear: invest heavily to gain share quickly, or risk them becoming Dogs. You should track the integration progress of PSI closely, as that is the largest immediate cash drain/investment.
- Invest heavily in PSI to realize synergies.
- Monitor market share gains in cryogenics.
- Track R&D spend versus new contract wins in defense electronics.
- Assess the capital required for the next M&A target.
Finance: draft 13-week cash view by Friday.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.